🔴 Structure Therapeutics is trading 4.6% down in pre-market with no clear catalyst identified

Structure Therapeutics is trading 4.6% down at $26.32 in pre-market on October 6, 2026, with no fresh company-specific announcement identified to explain the move.

• The supplied alert context also noted no clear company catalyst for the preceding session.
• Investors remain focused on obesity-drug competition, including recent positive results from rival Viking Therapeutics, but reporting does not establish this as the direct cause of the drop.
• Broader indices are modestly higher, so market direction does not explain the move.